Market Research Future (MRFR)’s report reveals that the Global Microarray Analysis Market is likely to strike a CAGR of 9.8% during the forecast period 2017 to 2023. The rising incidence of cancer has fueled demand for microarray analysis in the global market. According to a report published by the National Institute of Health (NIH), the estimated count of new cancer cases in the U.S. is likely to reach 1,735,350 mark by the end of 2018.
The growth trajectory of the microarray analysis market is guided by the rising burden of chronic diseases coupled with an increasing need for research in the pharmaceutical industry. Microarray analysis has improved results of genetic testing and is extensively used for diagnosis of infectious diseases which is prognosticated to expedite the expansion of the microarray analysis market over the assessment period.
Microarray analysis has led to significant development in the field of genetics which when coupled with high healthcare expenditure is projected to have a positive influence on the expansion of the microarray analysis market during the review period.
Microarray Analysis Market – Key Players
Some major market players in Global Microarray Marker are as follows: Affymetrix, Inc., Agilent Technologies, Inc., Sequenom, Inc., Roche NimbleGen, Illumnia, Inc., and Applied Microarrays. Other companies operating in the global microarrays market are biome rieux SA, Discerna, Gyros AB, Luminex Corporation, NextGen Sciences PLC. And ProteoGenix.
Get Free Sample Report @ https://www.marketresearchfuture.com/sample_request/896
Microarray Analysis Market – Segmentation
By technology, the Global Microarray Analysis Market is segmented into DNA microarray, PCR, NGS, SAGE, northern blotting, and others.
By consumables, the microarray analysis market has been segmented into DNA chips, DNA microarrays, protein microarrays, cellular microarrays, chemical compound microarrays, antibody microarrays, and others.
By services, the global microarray analysis market is segmented into gene profiling, bioinformatics, and others.
By applications, the microarray analysis market has been segmented into research, drug discovery, diagnostic and others.
Mar 2018, foil-based measuring chip which uses the microarray analysis platform MCR has been used in an outbreak of Legionnaires’ disease, finding the exact source as quickly as possible is essential to preventing further infections. The system can be successfully positioned for environmental hygiene as well as clinical diagnostics in combination with a second, a DNA-based method; the system can even distinguish between dead and living Legionella pathogens.
In September 2018, an international clinical diagnostics specialist, Novacyt’s molecular testing division, Primerdesign Ltd. has partnered with Applied Microarrays, Inc. (AMI), a specialist in microarrays.
In October 2018, a team of researchers led by a professor of Louisiana State University has developed an accessible way to test for the “BReast CAncer gene one.” He has proposed the use of portable fluorescence microarray-based imaging system called the FluoroZen for DNA microarray analysis.
In October 2018, TP Therapeutics, a clinical-stage precision oncology company has entered into an agreement with Almac Diagnostic Services, a global precision medicine company for development and commercialization of next-generation sequencing (NGS) companion diagnostic (CDx) for repotrectinib.
Drivers and Constraints Impacting the Market:
With the growing focus on drug discovery and development, increasing prevalence of genetic disorders coupled with growing demand for personalized medicines, the global market is likely to trigger during the forecast period. Microarray analysis is used to understand gene patterns in tumors and also detect cancer biomarker. Thus, the growing prevalence of cancer along with rising investment for cancer research is estimated to fuel the market growth.
On the flip side, high cost associated with diagnosis, inaccurate results, and contamination is estimated to inhibit the market growth in the coming years.
Microarray Analysis Market – Regional Analysis
The regional analysis of the market includes regions such as APAC, North America, Latin America, Europe, Middle East and Africa. The Americas are accredited with a major share in the microarray analysis market globally due to the occurrence of a well-developed healthcare sector and government support for research & development. The European region is another major market for microarray analysis which is followed by the Asia Pacific region. The existence of huge cancer population and rising need for improved diagnostic treatment has driven the European market. Japan majorly occupies the Asia Pacific microarray analysis market. China and India are the rapidly developing markets for microarray analysis. The Middle East & Africa region have the smallest share of this market.
Browse Complete 115 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/microarray-analysis-market-896
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312